Asia Deal Watch: Emmaus, Kainos Pursue R&D In Cancers With Limited Therapy Options

 
• By Ian Haydock, Jung Won Shin, and Joseph Haas

Plus deals involving WuXi AppTec/OXGENE, Oscotec/Beatica, ReViral/LianBio, Wugen/HCW Biologics, Starton/Haisco, Shanghai Junshi/AstraZeneca, HitGen/Uppthera, Bridge/LegoChem, Macrogen/Lifex, BeiGene/Boston Immune

Asia Deal Watch

More from Deals

More from Business